Vanegas-Farfano D, Moguel-Gloria A

Language: English
References: 9
Page: 92-96
PDF size: 112.00 Kb.

ABSTRACT

Introduction. Both osteopenia and osteoporosis conforms a systemic, metabolic, and multifactorial disease considered a worldwide burden. It follows a different path in the young adult and has been poorly studied. Objective. To describe risk factors for osteopenia and osteoporosis in young adults, including metabolic syndrome criteria. Methods. We performed a descriptive, observational study at a private clinic in Mexico City. We included patients aged 30 to 49 years with osteopenia or osteoporosis, determined by forearm Tscore. Results. We included 60 women and 40 men, with average age 43 years old, and average T-score -1.8. Most frequently reported risk factors were physical inactivity (35%), smoking (31%), nulliparity (13%), and urinary crystals on 12%. Almost half (45%) of patients had metabolic syndrome criteria. There was no correlation between T-score and metabolic variables. Conclusion. A high suspicion index for osteopenia and osteoporosis in young adults may help to identify and treat modifiable risk factors. Prospective and large-scale population studies are needed to assess the impact of each risk factor.

REFERENCES

1. Carlos F, Clark P, Galindo-Suárez RM, Chico-Barba LG. Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico. Arch Osteoporos 2013; 8: 125.

2. Guía de Práctica Clínica: Diagnóstico y Tratamiento de Osteoporosis en el Adulto. México: Secretaría de Salud; 2014.

3. FRAX(®) Bone Mineral Density Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference. Lewiecki EM, Compston JE, Miller PD, Adachi JD, Adams JE, Leslie WD, Kanis JA; FRAX(®) Position Development Conference Members. J Clin Densitom 2011; 14(3): 223-5.

4. Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM; AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 2010;16(Suppl. 3): 1-37. Órgano de Difusión de la Sociedad de Médicos Revista de Investigación

5. Peris Bernal P. Osteoporosis in young individuals. Reumatol Clin 2010; 6(4): 217-23.

6. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet 2005; 366(9491): 1059-62.

7. Gómez-García F, Vázquez-Martínez JL, Lara-Rodríguez Mde L. Osteoporosis and osteopenia in female health workers from Mexico City. Acta Ortop Mex 2008; 22(5): 292-302.

8. Wacher-Rodarte N. Epidemiología del síndrome metabólico. Gac Méd Méx 2009; 145(5): 384-91.

9. Zarzuelo A. Fibra. En: INTUCAM Alimentos Funcionales. Aproximación a una nueva alimentación. Madrid, España: Dirección General de Salud Pública y Alimentación.